Use of metformin was associated with a 16% reduced risk for overall mortality in patients with type 2 diabetes and pancreatic cancer. 

Patients with T2DM may be at an increased risk of lower muscle performance and strength, putting them at risk for developing sarcopenia. 

Researchers found larger amount of gut microbiota in the digestive system of individuals with type 2 diabetes than in those without the disease. 

Is there a difference in the effect on glucose control and metabolic health when people exercise in the morning vs. In the afternoon?

Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin II receptor blockers (ARBs) can allow coronavirus entry, leading to pulmonary adverse effects.

The mechanisms by which estrogens improve glucose homeostasis are not completely understood.

Old drug, new purpose? Analysis found HIV and Hepatitis B patients treated with NRTIs had significantly lower incidence of type 2 diabetes.

How often are opioids being initiated for diabetic peripheral neuropathy (DPN) in newly diagnosed patients?

New vaccines targeting viruses linked with type 1 diabetes may offer protection to patients with high-risk factors.

The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events.